Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126088793 | 12608879 | 3 | F | 20160701 | 20160822 | 20160730 | 20160831 | EXP | JP-AMGEN-JPNSP2016098694 | AMGEN | 58.00 | YR | A | F | Y | 47.00000 | KG | 20160831 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126088793 | 12608879 | 1 | PS | G-LASTA | PEGFILGRASTIM | 1 | Subcutaneous | 3.6 MG, QD | U | 125031 | 3.6 | MG | SOLUTION FOR INJECTION | QD | |||||
| 126088793 | 12608879 | 2 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous drip | 108 MG, QD | 0 | 108 | MG | INJECTION | QD | ||||||
| 126088793 | 12608879 | 3 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 880 MG, QD | 0 | 880 | MG | INJECTION | QD | ||||||
| 126088793 | 12608879 | 4 | C | SEROTONE | AZASETRON HYDROCHLORIDE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | TABLET | QD | ||||||
| 126088793 | 12608879 | 5 | C | RESTAMIN | DIPHENHYDRAMINE | 1 | Oral | 50 MG, QD | 0 | 50 | MG | TABLET | QD | ||||||
| 126088793 | 12608879 | 6 | C | DECADRON | DEXAMETHASONE | 1 | Intravenous drip | 6.6 MG, QD | 36 | MG | 0 | 6.6 | MG | INJECTION | QD | ||||
| 126088793 | 12608879 | 7 | C | DECADRON | DEXAMETHASONE | 1 | Oral | 4 MG, TID | 36 | MG | 0 | 4 | MG | INJECTION | TID | ||||
| 126088793 | 12608879 | 8 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG, UNK | 0 | 150 | MG | TABLET | |||||||
| 126088793 | 12608879 | 9 | C | NAUZELIN | DOMPERIDONE | 1 | Oral | 10 DF, UNK | 0 | 10 | DF | ||||||||
| 126088793 | 12608879 | 10 | C | SELBEX | TEPRENONE | 1 | Oral | 50 MG, UNK | 0 | 50 | MG | CAPSULE | |||||||
| 126088793 | 12608879 | 11 | C | CRAVIT | LEVOFLOXACIN | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126088793 | 12608879 | 1 | Colony stimulating factor prophylaxis |
| 126088793 | 12608879 | 2 | Breast cancer |
| 126088793 | 12608879 | 3 | Breast cancer |
| 126088793 | 12608879 | 11 | Pyrexia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126088793 | 12608879 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126088793 | 12608879 | Pleural effusion | |
| 126088793 | 12608879 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126088793 | 12608879 | 1 | 20160623 | 0 | ||
| 126088793 | 12608879 | 2 | 20160622 | 0 | ||
| 126088793 | 12608879 | 3 | 20160622 | 0 | ||
| 126088793 | 12608879 | 4 | 20160622 | 0 | ||
| 126088793 | 12608879 | 5 | 20160622 | 0 | ||
| 126088793 | 12608879 | 6 | 20160622 | 0 | ||
| 126088793 | 12608879 | 7 | 20160623 | 20160625 | 0 | |
| 126088793 | 12608879 | 8 | 20160622 | 0 | ||
| 126088793 | 12608879 | 9 | 20160622 | 0 | ||
| 126088793 | 12608879 | 10 | 20160622 | 0 | ||
| 126088793 | 12608879 | 11 | 20160701 | 0 |